Biologics for Psoriasis
Cutis. 2016 March;97(3):
Author and Disclosure Information
As part of our commitment to resident education, Cutis is excited to offer this monthly section with board-relevant, easy-to-review material.
This study material discusses the current US Food and Drug Administration–approved biologic medications for psoriasis and psoriatic arthritis, including the mechanism of action, dosing, and side effects.
2. Which biologic is dosed based on body weight?
a. adalimumab
b. etanercept
,c. infliximab
d. secukinumab
e. ustekinumab